lonafarnib has been researched along with Cancer of Pancreas in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, B; Lee, MH; Pan, J; Su, CH; Sun, L; Xu, ZX; Yeung, SC; Zhao, R | 1 |
Bishop, WR; Chen, J; Ferrari, E; Gurnani, M; Hajian, G; Lipari, P; Liu, M; Malkowski, M; Nielsen, LL; Shi, B; Yaremko, B | 1 |
2 other study(ies) available for lonafarnib and Cancer of Pancreas
Article | Year |
---|---|
Autophagy induced by farnesyltransferase inhibitors in cancer cells.
Topics: Apoptosis; Autophagy; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Pancreatic Neoplasms; Piperidines; Polyenes; Polyunsaturated Alkamides; Protein Kinases; Pyridines; RNA, Small Interfering; Signal Transduction; TOR Serine-Threonine Kinases | 2008 |
Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models.
Topics: Adenocarcinoma; Adenoviruses, Human; Alkyl and Aryl Transferases; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Survival; Drug Synergism; Female; Genes, ras; Humans; Male; Mice; Mice, Nude; Mice, SCID; Mice, Transgenic; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Piperidines; Prostatic Neoplasms; Pyridines; Teratocarcinoma; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1999 |